Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
markets
Globalisation declining? Not in investor portfolios
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,849.40 | 17.50 | 0.22% |
| CAC 40 | 7,923.67 | 61.26 | -0.77% |
| DAX 40 | 17,944.42 | 12.25 | 0.07% |
| Dow JONES (US) | 37,903.29 | 87.37 | 0.23% |
| FTSE 100 | 8,149.75 | 28.51 | 0.35% |
| HKSE | 18,207.13 | 444.10 | 2.50% |
| NASDAQ | 15,605.48 | 52.34 | -0.33% |
| Nikkei 225 | 38,236.07 | 37.98 | -0.10% |
| NZX 50 Index | 11,874.04 | 6.46 | 0.05% |
| S&P 500 | 5,018.39 | 17.30 | -0.34% |
| S&P/ASX 200 | 7,587.00 | 17.10 | 0.23% |
| SSE Composite Index | 3,104.82 | 8.22 | -0.26% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Tietto Minerals Ltd TIE | 0.68 | 0.01 | 0.74% |
| Red 5 Ltd RED | 0.43 | 0.02 | 3.61% |
| Alumina Ltd AWC | 1.52 | 0.02 | -1.30% |
| Telstra Group Ltd TLS | 3.59 | 0.05 | -1.37% |
| Mesoblast Ltd MSB | 1.07 | 0.03 | -2.73% |
| BrainChip Holdings Ltd BRN | 0.25 | 0.04 | -12.28% |
| Pantoro Ltd PNR | 0.09 | 0.00 | 1.19% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Melbana Energy Ltd MAY | 0.05 | 0.01 | -9.09% |
| The Star Entertainment Group Ltd SGR | 0.41 | 0.01 | 2.50% |